共 43 条
- [31] LV305, a dendritic cell-targeting integration-deficient ZVex™-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response MOLECULAR THERAPY-ONCOLYTICS, 2016, 3
- [33] Murine FLT3 Ligand-Derived Dendritic Cell-Mediated Early Immune Responses Are Critical to Controlling Cell-Free Human T Cell Leukemia Virus Type 1 Infection JOURNAL OF IMMUNOLOGY, 2011, 186 (01): : 390 - 402
- [39] The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases MELANOMA RESEARCH, 2020, 30 (01) : 85 - 101